全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Surgical Morbidity of Simultaneous Kidney and Pancreas Transplantation: A Single-Centre Experience in the Tacrolimus Era

DOI: 10.5402/2013/685850

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction. Simultaneous pancreas and kidney (SPK) transplantation is performed to restore normoglycaemia and renal function in patients with Type I diabetes mellitus and end-stage renal failure. We aimed to evaluate the impact of major postoperative complications to patient and graft survival outcomes. Method. Using a prospectively collected database over a 10-year period, major postoperative complications requiring return to operating theatre as well as patient and graft survival outcomes were analysed retrospectively. Results. Between January 2001 and May 2010, 165 patients underwent first-time SPK transplantation. Median age of recipients was 39.8 years (range, 16.9–53.2). Enteric drainage was used in 149 patients, and bladder drainage was used in 16. Median follow-up time was 5.2 years (range 1.1–10.3). Fifty-six patients (34%) returned to operating theatre at least once. Pancreatic allograft loss secondary to vascular thrombosis occurred in 12 patients (7%), and 2 patients (1.2%) required transplant pancreatectomy due to debilitating pancreatic enzyme leaks. At 1 and 5 years, patient survival was 98% and 94%; pancreas graft survival, 86% and 77%; kidney graft survival 96% and 89%, respectively. Conclusion. SPK is a safe and effective treatment for Type I diabetes mellitus and end-stage renal failure although surgical reintervention is required in approximately one-third of patients. Preventing vascular thrombosis remains a major challenge. 1. Introduction The first successful simultaneous pancreas-kidney (SPK) transplantation was performed at the University of Minnesota Hospital in 1966 [1]. Since then, SPK has become an effective treatment modality for patients with Type 1 diabetes mellitus (T1DM) and end-stage renal failure [2]. Despite numerous advances in surgical techniques, organ preservation, and immunosuppression over the past 25 years, SPK is still associated with significant morbidity and rate of transplant graft loss remains significant [3]. Surgical complications in particular graft thrombosis and haemorrhage can lead to reintervention, graft loss, and increased length of hospital stay [4]. Our aim was to review the experience of SPK transplantation at the National Pancreas Transplant Unit (NPTU) in Australia over the last 10 years, focusing on the incidence of major postoperative complications and the reasons for graft loss. We also aimed to identify risk factors leading to graft loss within our cohort. 2. Patients and Methods A retrospective study was conducted on 165 first-time SPK transplants performed at the NPTU between January

References

[1]  W. D. Kelly, R. C. Lillehei, F. K. Merkel, Y. Idezuki, and F. G. Goetz, “Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy,” Surgery, vol. 61, no. 6, pp. 827–837, 1967.
[2]  S. A. White, J. A. Shaw, and D. E. Sutherland, “Pancreas transplantation,” The Lancet, vol. 373, no. 9677, pp. 1808–1817, 2009.
[3]  A. O. Ojo, H. U. Meier-Kriesche, J. A. Hanson et al., “The impact of simultaneous pancreas-kidney transplantation on long-term patient survival,” Transplantation, vol. 71, no. 1, pp. 82–90, 2001.
[4]  A. Humar, T. Ramcharan, R. Kandaswamy, R. W. G. Gruessner, A. C. Gruessner, and D. E. R. Sutherland, “Technical failures after pancreas transplants: why grafts fail and the risk factors—a multivariate analysis,” Transplantation, vol. 78, no. 8, pp. 1188–1192, 2004.
[5]  V. W. T. Lam, H. C. C. Pleass, W. Hawthorne, and R. D. M. Allen, “Evolution of pancreas transplant surgery,” ANZ Journal of Surgery, vol. 80, no. 6, pp. 411–418, 2010.
[6]  V. W. T. Lam, K. Wong, W. Hawthorne et al., “The linear cutting stapler for enteric anastomosis: a new technique in pancreas transplantation,” Transplant International, vol. 19, no. 11, pp. 915–918, 2006.
[7]  J. Hintze, NCSS, NCSS, LLC, Kaysville, Utah, USA, 2007.
[8]  R. W. Bilous, S. M. Mauer, D. E. R. Sutherland, J. S. Najarian, F. C. Goetz, and M. W. Steffes, “The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes,” New England Journal of Medicine, vol. 321, no. 2, pp. 80–85, 1989.
[9]  P. Fioretto, M. W. Steffes, D. E. R. Sutherland, F. C. Goetz, and M. Mauer, “Reversal of lesions of diabetic nephropathy after pancreas transplantation,” New England Journal of Medicine, vol. 339, no. 2, pp. 69–75, 1998.
[10]  R. D. M. Allen, I. S. Al-Harbi, J. G. L. Morris et al., “Diabetic neuropathy after pancreas transplantation: determinants of recovery,” Transplantation, vol. 63, no. 6, pp. 830–838, 1997.
[11]  J. W. Jukema, Y. F. C. Smets, J. W. Van Der Pijl et al., “Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes,” Diabetes Care, vol. 25, no. 5, pp. 906–911, 2002.
[12]  A. O. Gaber, M. N. Wicks, D. K. Hathaway, and B. S. Burlew, “Sustained improvements in cardiac geometry and function following kidney-pancreas transplantation,” Cell Transplantation, vol. 9, no. 6, pp. 913–918, 2000.
[13]  C. Troppmann, “Complications after pancreas transplantation,” Current Opinion in Organ Transplantation, vol. 15, no. 1, pp. 112–118, 2010.
[14]  A. Manrique, C. Jiménez, R. M. López et al., “Relaparotomy after pancreas transplantation: causes and outcomes,” Transplantation Proceedings, vol. 41, no. 6, pp. 2472–2474, 2009.
[15]  W. Steurer, J. Malaise, W. Mark, A. Koenigsrainer, and R. Margreiter, “Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols,” Nephrology Dialysis Transplantation, vol. 20, supplement 2, pp. ii54–ii61, 2005.
[16]  A. C. Gruessner and D. E. R. Sutherland, “Pancreas transplant outcomes for United States (US) and non- US cases as reported to the United Network for Organ Sharing (UNOS) and the International Prancreas Transplant Registry (IPTR) as of June 2004,” Clinical Transplantation, vol. 19, no. 4, pp. 433–455, 2005.
[17]  R. D. Bloom, M. Olivares, L. Rehman, R. M. Raja, S. Yang, and F. Badosa, “Long-term pancreas allograft outcome in simultaneous pancreas-kidney transplantation: a comparison of enteric and bladder drainage,” Transplantation, vol. 64, no. 12, pp. 1689–1695, 1997.
[18]  H. W. Sollinger, J. S. Odorico, Y. T. Becker, A. M. D'Alessandro, and J. D. Pirsch, “One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up,” Annals of Surgery, vol. 250, no. 4, pp. 618–630, 2009.
[19]  C. Jiménez-Romero, A. Manrique, J. C. Meneu et al., “Compative study of bladder versus enteric drainage in pancreas transplantation,” Transplantation Proceedings, vol. 41, no. 6, pp. 2466–2468, 2009.
[20]  D. P. Hickey, R. Bakthavatsalam, C. A. Bannon, K. O'Malley, J. Corr, and D. M. Little, “Urological complications of pancreatic transplantation,” Journal of Urology, vol. 157, no. 6, pp. 2042–2048, 1997.
[21]  M. Adamec, L. Janou?ek, K. Lipár et al., “A prospective comparison of bladder versus enteric drainage in vascularized pancreas transplantation,” Transplantation Proceedings, vol. 36, no. 4, pp. 1093–1094, 2004.
[22]  H. W. Sollinger, “Pancreatic transplantation and vascular graft thrombosis,” Journal of the American College of Surgeons, vol. 182, no. 4, pp. 362–363, 1996.
[23]  F. L. Luan, M. Kommareddi, D. M. Cibrik, M. Samaniego, and A. O. Ojo, “Influence of recipient race on the outcome of simultaneous pancreas and kidney transplantation,” American Journal of Transplantation, vol. 10, no. 9, pp. 2074–2081, 2010.
[24]  M. S. Sampaio, P. N. Reddy, H. T. Kuo et al., “Obesity was associated with inferior outcomes in simultaneous pancreas kidney transplant,” Transplantation, vol. 89, no. 9, pp. 1117–1125, 2010.
[25]  P. Schenker, O. Vonend, N. Ertas et al., “Incidence of pancreas graft thrombosis using low-molecular-weight heparin,” Clinical Transplantation, vol. 23, no. 3, pp. 407–414, 2009.
[26]  L. Benetti, X. Bassi, G. Zamboni et al., “Pancreaticoduodenal graft in the rat: an original microsurgical technique,” European Surgical Research, vol. 21, no. 3-4, pp. 162–167, 1989.
[27]  K. Waki, P. I. Terasaki, and T. Kadowaki, “Long-term pancreas allograft survival in simultaneous pancreas-kidney transplantation by era: UNOS registry analysis,” Diabetes Care, vol. 33, no. 8, pp. 1789–1791, 2010.
[28]  A. K. Israni, H. I. Feldman, K. J. Propert, M. Leonard, and K. C. Mange, “Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival,” American Journal of Transplantation, vol. 5, no. 2, pp. 374–382, 2005.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413